Neurology and Neurosurgery - Global Neurology Academy

209-224 of 455

Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
- Natalie Bareis, PhD, LMSW
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiers
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiers
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of Schizophrenia
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
- Steven Paul, MD
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiers
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
- Maxwell H. Levy, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
- Steven Paul, MD
Navigating Myasthenia Gravis in Adolescents and Young Adults
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
- Jonathan Strober, MD
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
On the Frontlines of Schizophrenia
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
- Desiree Matthews, PMHNP-BC
Spotting the Signs: Early Identification and Management of Schizophrenia
Spotting the Signs: Early Identification and Management of Schizophrenia
On the Frontlines of Schizophrenia
Spotting the Signs: Early Identification and Management of Schizophrenia
- Desiree Matthews, PMHNP-BC
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
- Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
Challenges in DMD: Understanding the Height Factor
NeuroFrontiers
Challenges in DMD: Understanding the Height Factor
Schizophrenia Care: Improving Social Cognition and Motivation
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of Schizophrenia
Schizophrenia Care: Improving Social Cognition and Motivation
- Michael Green, PhD
The Evolving gMG Treatment Landscape
The Evolving gMG Treatment Landscape
NeuroFrontiers
The Evolving gMG Treatment Landscape
- Henry Kaminski, MD
FcRn Inhibitors: A Potential New Targeted Therapy Option
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiers
FcRn Inhibitors: A Potential New Targeted Therapy Option
- Nicholas J. Silvestri, MD
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiers
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy

14/11